Arvee Laboratories (India) Limited (ARVEE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.043x

Based on the latest financial reports, Arvee Laboratories (India) Limited (ARVEE) has a cash flow conversion efficiency ratio of 0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs13.56 Million ≈ $146.61K USD) by net assets (Rs314.41 Million ≈ $3.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Arvee Laboratories (India) Limited (ARVEE) defensive interval to measure how many days the company can operate on defensive assets alone.

Arvee Laboratories (India) Limited - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Arvee Laboratories (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Arvee Laboratories (India) Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Arvee Laboratories (India) Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Law Debenture Corp
LSE:LWDB
0.023x
Haily Group Bhd
KLSE:0237
0.070x
Maisons du Monde SAS
PA:MDM
-0.014x
Sensei Biotherapeutics Inc
NASDAQ:SNSE
-0.056x
SKY E&M Co. Ltd
KQ:131100
0.027x
Orbital Corporation Ltd
AU:OEC
0.024x
Caldwell Partners International Inc
TO:CWL
-0.159x
BMG Resources Ltd
AU:BMG
-0.022x

Annual Cash Flow Conversion Efficiency for Arvee Laboratories (India) Limited (2013–2025)

The table below shows the annual cash flow conversion efficiency of Arvee Laboratories (India) Limited from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Arvee Laboratories (India) Limited.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs312.61 Million
≈ $3.38 Million
Rs1.19 Million
≈ $12.86K
0.004x -96.98%
2024-03-31 Rs291.14 Million
≈ $3.15 Million
Rs36.64 Million
≈ $396.20K
0.126x +20.56%
2023-03-31 Rs280.62 Million
≈ $3.03 Million
Rs29.29 Million
≈ $316.75K
0.104x +266.76%
2022-03-31 Rs239.42 Million
≈ $2.59 Million
Rs6.81 Million
≈ $73.68K
0.028x -64.33%
2021-03-31 Rs214.38 Million
≈ $2.32 Million
Rs17.11 Million
≈ $184.99K
0.080x -85.57%
2020-03-31 Rs186.89 Million
≈ $2.02 Million
Rs103.34 Million
≈ $1.12 Million
0.553x -3.74%
2019-03-31 Rs164.62 Million
≈ $1.78 Million
Rs94.56 Million
≈ $1.02 Million
0.574x +35.56%
2018-03-31 Rs141.99 Million
≈ $1.54 Million
Rs60.16 Million
≈ $650.63K
0.424x -44.76%
2017-03-31 Rs41.94 Million
≈ $453.55K
Rs32.17 Million
≈ $347.88K
0.767x -67.47%
2016-03-31 Rs26.41 Million
≈ $285.60K
Rs62.26 Million
≈ $673.36K
2.358x -61.19%
2015-03-31 Rs14.15 Million
≈ $153.01K
Rs85.94 Million
≈ $929.39K
6.074x +6203.72%
2014-03-31 Rs30.62 Million
≈ $331.12K
Rs-3.05 Million
≈ $-32.95K
-0.100x -100.24%
2013-03-31 Rs930.00K
≈ $10.06K
Rs38.55 Million
≈ $416.93K
41.454x --

About Arvee Laboratories (India) Limited

NSE:ARVEE India Specialty Chemicals
Market Cap
$19.64 Million
Rs1.82 Billion INR
Market Cap Rank
#25195 Global
#1401 in India
Share Price
Rs164.83
Change (1 day)
-3.43%
52-Week Range
Rs133.86 - Rs290.78
All Time High
Rs306.70
About

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroi… Read more